Inventor · disambiguated record
Jay A. Berzofsky
Also filed as: BERZOFSKY JAY · BERZOFSKY JAY A · BERZOFSKY JAY ARTHUR
49 granted patents·20 pending applications·513 citations·filing 1987–2025
98Inventor score
Top patents by PatentIndex Score
69 records- 0187US8835613B2β-mannosylceramide and stimulation of NKT cell anti-tumor immunityBERZOFSKY JAY A·Filed 2011·Granted Sep 16, 2014·13 cites·24 claims
- 0286US7507538B2Human papilloma virus immunoreactive peptidesUS HEALTH·Filed 2007·Granted Mar 24, 2009·3 cites·15 claims
- 0385US6592872B1Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion proteinUS HEALTH·Filed 1997·Granted Jul 15, 2003·62 cites·10 claims
- 0484US9421254B2Immunostimulatory combinations of TLR ligands and methods of useBERZOFSKY JAY A·Filed 2008·Granted Aug 23, 2016·9 cites·10 claims
- 0582US7097965B2Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion proteinUS HEALTH·Filed 2003·Granted Aug 29, 2006·11 cites·6 claims
- 0678US6749856B1Mucosal cytotoxic T lymphocyte responsesUS HEALTH·Filed 1998·Granted Jun 15, 2004·54 cites·40 claims
- 0777US8043623B2Immunogenic peptides for the treatment of prostate and breast cancerUS GOV HEALTH & HUMAN SERV·Filed 2009·Granted Oct 25, 2011·1 cites·25 claims
- 0877US7867977B2Immunogenic peptides and methods of use for treating and preventing cancerUS HEALTH·Filed 2006·Granted Jan 11, 2011·2 cites·17 claims
- 0977US7189513B2Human papilloma virus immunoreactive peptidesUS HEALTH·Filed 2002·Granted Mar 13, 2007·3 cites·6 claims
- 1076US7541035B2Immunogenic peptides for the treatment of prostate and breast cancerUS HEALTH·Filed 2004·Granted Jun 2, 2009·4 cites·25 claims
- 1174US4886782AMalarial immunogenUS HEALTH·Filed 1987·Granted Dec 12, 1989·49 cites·7 claims
- 1272US8663622B2Recombinant vaccine viruses expressing IL-15 and methods using the samePERERA LIYANAGE P·Filed 2003·Granted Mar 4, 2014·7 cites·16 claims
- 1370US9168291B2β-mannosylceramide and stimulation of NKT cell anti-tumor immunityUS OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICE·Filed 2014·Granted Oct 27, 2015·2 cites·22 claims
- 1470US5030449ASynthetic vaccine against AIDS virusUS HEALTH·Filed 1988·Granted Jul 9, 1991·38 cites·2 claims
- 1569US10876955B2Optical configuration methods for spectral scatter flow cytometryUS HEALTH·Filed 2018·Granted Dec 29, 2020·1 cites·27 claims
- 1669US5283323AMethod of producing immune responseUS ARMY·Filed 1991·Granted Feb 1, 1994·35 cites·15 claims
- 1768US10286050B2Multi-epitope TARP peptide vaccine and uses thereofUS HEALTH·Filed 2014·Granted May 14, 2019·2 cites·14 claims
- 1868US5939074AMultideterminant peptide antigensUS HEALTH·Filed 1995·Granted Aug 17, 1999·24 cites·12 claims
- 1967US6294322B1Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1US HEALTH·Filed 1993·Granted Sep 25, 2001·20 cites·5 claims
- 2067US5336758APeptides stimulating cytotoxic T cells immune to HIV RTUS HEALTH·Filed 1990·Granted Aug 9, 1994·23 cites·3 claims
- 2166US9394352B2Immunogenic POTE peptides and methods of useUS HEALTH·Filed 2014·Granted Jul 19, 2016·0 cites·18 claims
- 2265US7341726B2Modified HCV peptide immunogensUS SECRETARY DEPT OF HEALTH AN·Filed 2006·Granted Mar 11, 2008·0 cites·9 claims
- 2364US5932218AMultideterminant peptides eliciting helper T-lymphocyte, cytotoxic T-lymphocyte, and neutralizing antibody responses against HIV-1US HEALTH·Filed 1995·Granted Aug 3, 1999·21 cites·2 claims
- 2464US2025222016A13-o-sulfo-galactosylceramide analogs as activators of type ii nkt cells and uses thereofUS HEALTH·Filed 2025·Application pending·0 cites
- 2563US9206245B2Immunogenic peptides and methods of use for treating and preventing cancerUS HEALTH·Filed 2013·Granted Dec 8, 2015·0 cites·11 claims
- 2663US7731971B2Enhanced CTL epitope-containing HIV-1 reverse transcriptase polypeptidesUS HEALTH·Filed 2004·Granted Jun 8, 2010·0 cites·27 claims
- 2761US7074410B2Modified HCV peptide vaccinesUS HEALTH·Filed 2004·Granted Jul 11, 2006·0 cites·12 claims
- 2861US5997869APeptides containing a fusion joint of a chimeric protein encoded by DNA spanning a tumor-associated chromosomal translocation and their use as immunogensUS HEALTH·Filed 1995·Granted Dec 7, 1999·26 cites·22 claims
- 2960US12268700B23-o-sulfo-galactosylceramide analogs as activators of type II NKT cells and uses thereofUS HEALTH·Filed 2019·Granted Apr 8, 2025·0 cites·5 claims
- 3059US2015203830A1Compositions comprising nucleic acids encoding hiv-1 reverse transcriptase ctl epitopesGOVERNMENT OF THE US SECRETARY OF THE DEPARTMEN OF H·Filed 2014·Application pending·0 cites
- 3158US7094405B1Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipientsUS HEALTH·Filed 1999·Granted Aug 22, 2006·14 cites·7 claims
- 3257US5081226ASynthetic peptides sharing sequence homology with the HIV envelope proteinUS HEALTH·Filed 1990·Granted Jan 14, 1992·25 cites·5 claims
- 3357US2024173399A1Adjuvanted mucosal subunit vaccines for preventing sars-cov-2 transmission and infectionTHE US SECRETARY DEPART OF HEALTH AND HUMAN SERVICES·Filed 2022·Application pending·0 cites
- 3456US8871902B2Immunogenic POTE peptides and methods of useBERZOFSKY JAY A·Filed 2012·Granted Oct 28, 2014·0 cites·31 claims
- 3556US2005232897A1Mucosal cytotoxic T lymphocyte responsesUS HEALTH·Filed 2004·Application pending·0 cites
- 3654US8877914B2Compositions comprising nucleic acids encoding HIV-1 reverse transcriptase CTL epitopesBERZOFSKY JAY A·Filed 2010·Granted Nov 4, 2014·0 cites·2 claims
- 3754US5976541APotent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelopeUS HEALTH·Filed 1992·Granted Nov 2, 1999·14 cites·5 claims
- 3854US2003032050A1Methods and compositions using peptide-pulsed dendritic cells for stimulating cytotoxic T lymphocytes specific for tumor cells or virus-infected cellsGOVT OF THE U S A AS REPRESENT·Filed 2002·Application pending·0 cites
- 3954US2002048590A1Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion proteinFiled 2001·Application pending·0 cites
- 4053US5980899AIdentification of peptides that stimulate hepatitis C virus specific cytotoxic T cellsUS HEALTH·Filed 1992·Granted Nov 9, 1999·13 cites·7 claims
- 4153US2003086911A1Methods and compositions for the stimulation of human immunodeficiency virus-specific cytotoxic T lymphocytes employing autologous antigen-peripheral blood mononuclear cellsDEPT OF HEALTH AND HUMAN SERVI·Filed 2002·Application pending·0 cites
- 4252US8614304B2Immunogenic peptides and methods of use for treating and preventing cancerBERZOFSKY JAY A·Filed 2010·Granted Dec 24, 2013·0 cites·20 claims
- 4352US2014377306A1Recombinant vaccine viruses expressing il-15 and methods of using the sameUS HEALTH·Filed 2014·Application pending·0 cites
- 4451US11266726B2Compositions and methods for the treatment of HER2-expressing solid tumorsUS HEALTH·Filed 2016·Granted Mar 8, 2022·0 cites·14 claims
- 4551US2008267964A1Synergistic Effect of Tgf-Beta Blockade and Immunogenic Agents on TumorsTERABE MASAKI·Filed 2006·Application pending·0 cites
- 4651US2017165359A1Immunostimulatory combinations of tlr ligands and methods of useTHE US SECRETARY DEPT OF HEALTH & HUMAN SERVIC·Filed 2016·Application pending·0 cites
- 4750US5028425ASynthetic vaccine against P. falciparum malariaUS HEALTH·Filed 1988·Granted Jul 2, 1991·8 cites·2 claims
- 4850US2023241232A1Size-Dependent Brain and Lymphatic Distribution of Macromolecular Drug Delivery PlatformTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN·Filed 2021·Application pending·0 cites
- 4949US7691579B2Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogenUS HEALTH·Filed 2006·Granted Apr 6, 2010·0 cites·20 claims
- 5046US2013171178A1Immunogenic Peptides of Xage-1BERZOFSKY JAY A·Filed 2004·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →